Electromed (ELMD) vs Hyperfine (HYPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Electromed (ELMD) has outperformed Hyperfine (HYPR) over the past year, gaining 10.7% versus a loss of 55.0%. Over five years, ELMD leads with a +153.0% price change compared with -90.5% for HYPR. Electromed is the larger company by market cap ($230.4 million vs $99.7 million), about 2.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | HYPR |
|---|---|---|
| Share price | $27.80 | $0.9401 |
| Market cap | $230.38M | $99.70M |
| 1-day change | -1.42% | +10.73% |
| YTD return | -4.53% | -3.97% |
| 1-year return | +10.67% | -55.02% |
| 5-year return | +152.96% | -90.54% |
| P/E ratio (TTM) | 21.38 | — |
| Forward P/E | 45.57 | — |
| EPS (TTM) | $1.30 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $2.22 |
| 52-week low | $23.01 | $0.754 |
| Distance from 52-week high | -41.35% | -57.65% |
| Analyst consensus | none | none |
| Avg. price target upside | +74.46% | +115.93% |
| Average volume | 104.86K | 611.89K |
| Shares outstanding | 8.29M | 90.99M |
| Employees | 195 | 102 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Electromed is about 2.3 times larger than Hyperfine by market value ($230.38M vs $99.70M).
- ELMD has outperformed HYPR by 65.7 percentage points over the past year.
- The two companies sit in different sectors: Electromed in Health Care and Hyperfine in Healthcare.
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About Hyperfine
HYPR stock →Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Healthcare · Medical Devices · 102 employees
ELMD vs HYPR FAQ
Which is bigger, Electromed or Hyperfine?
Electromed (ELMD) is larger, with a market capitalization of $230.38M compared with $99.70M for Hyperfine (HYPR).
Which stock has performed better over the past year, ELMD or HYPR?
ELMD returned +10.67% over the past 12 months, compared with -55.02% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are Electromed and Hyperfine in the same industry?
No. Electromed is in the Health Care sector, while Hyperfine is in Healthcare.